Cargando…
Addressing Current Challenges in OSL Dosimetry Using MgB(4)O(7):Ce,Li: State of the Art, Limitations and Avenues of Research
The objective of this work is to review and assess the potential of [Formula: see text]:Ce,Li to fill in the gaps where the need for a new material for optically stimulated luminescence (OSL) dosimetry has been identified. We offer a critical assessment of the operational properties of [Formula: see...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142933/ https://www.ncbi.nlm.nih.gov/pubmed/37109886 http://dx.doi.org/10.3390/ma16083051 |
_version_ | 1785033730799173632 |
---|---|
author | Bossin, Lily Plokhikh, Igor Christensen, Jeppe Brage Gawryluk, Dariusz Jakub Kitagawa, Yuuki Leblans, Paul Tanabe, Setsuhisa Vandenbroucke, Dirk Yukihara, Eduardo Gardenali |
author_facet | Bossin, Lily Plokhikh, Igor Christensen, Jeppe Brage Gawryluk, Dariusz Jakub Kitagawa, Yuuki Leblans, Paul Tanabe, Setsuhisa Vandenbroucke, Dirk Yukihara, Eduardo Gardenali |
author_sort | Bossin, Lily |
collection | PubMed |
description | The objective of this work is to review and assess the potential of [Formula: see text]:Ce,Li to fill in the gaps where the need for a new material for optically stimulated luminescence (OSL) dosimetry has been identified. We offer a critical assessment of the operational properties of [Formula: see text]:Ce,Li for OSL dosimetry, as reviewed in the literature and complemented by measurements of thermoluminescence spectroscopy, sensitivity, thermal stability, lifetime of the luminescence emission, dose response at high doses (>1000 Gy), fading and bleachability. Overall, compared with [Formula: see text] , for example, [Formula: see text]:Ce,Li shows a comparable OSL signal intensity following exposure to ionizing radiation, a higher saturation limit (ca 7000 Gy) and a shorter luminescence lifetime (31.5 ns). [Formula: see text]:Ce,Li is, however, not yet an optimum material for OSL dosimetry, as it exhibits anomalous fading and shallow traps. Further optimization is therefore needed, and possible avenues of investigation encompass gaining a better understanding of the roles of the synthesis route and dopants and of the nature of defects. |
format | Online Article Text |
id | pubmed-10142933 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-101429332023-04-29 Addressing Current Challenges in OSL Dosimetry Using MgB(4)O(7):Ce,Li: State of the Art, Limitations and Avenues of Research Bossin, Lily Plokhikh, Igor Christensen, Jeppe Brage Gawryluk, Dariusz Jakub Kitagawa, Yuuki Leblans, Paul Tanabe, Setsuhisa Vandenbroucke, Dirk Yukihara, Eduardo Gardenali Materials (Basel) Article The objective of this work is to review and assess the potential of [Formula: see text]:Ce,Li to fill in the gaps where the need for a new material for optically stimulated luminescence (OSL) dosimetry has been identified. We offer a critical assessment of the operational properties of [Formula: see text]:Ce,Li for OSL dosimetry, as reviewed in the literature and complemented by measurements of thermoluminescence spectroscopy, sensitivity, thermal stability, lifetime of the luminescence emission, dose response at high doses (>1000 Gy), fading and bleachability. Overall, compared with [Formula: see text] , for example, [Formula: see text]:Ce,Li shows a comparable OSL signal intensity following exposure to ionizing radiation, a higher saturation limit (ca 7000 Gy) and a shorter luminescence lifetime (31.5 ns). [Formula: see text]:Ce,Li is, however, not yet an optimum material for OSL dosimetry, as it exhibits anomalous fading and shallow traps. Further optimization is therefore needed, and possible avenues of investigation encompass gaining a better understanding of the roles of the synthesis route and dopants and of the nature of defects. MDPI 2023-04-12 /pmc/articles/PMC10142933/ /pubmed/37109886 http://dx.doi.org/10.3390/ma16083051 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Bossin, Lily Plokhikh, Igor Christensen, Jeppe Brage Gawryluk, Dariusz Jakub Kitagawa, Yuuki Leblans, Paul Tanabe, Setsuhisa Vandenbroucke, Dirk Yukihara, Eduardo Gardenali Addressing Current Challenges in OSL Dosimetry Using MgB(4)O(7):Ce,Li: State of the Art, Limitations and Avenues of Research |
title | Addressing Current Challenges in OSL Dosimetry Using MgB(4)O(7):Ce,Li: State of the Art, Limitations and Avenues of Research |
title_full | Addressing Current Challenges in OSL Dosimetry Using MgB(4)O(7):Ce,Li: State of the Art, Limitations and Avenues of Research |
title_fullStr | Addressing Current Challenges in OSL Dosimetry Using MgB(4)O(7):Ce,Li: State of the Art, Limitations and Avenues of Research |
title_full_unstemmed | Addressing Current Challenges in OSL Dosimetry Using MgB(4)O(7):Ce,Li: State of the Art, Limitations and Avenues of Research |
title_short | Addressing Current Challenges in OSL Dosimetry Using MgB(4)O(7):Ce,Li: State of the Art, Limitations and Avenues of Research |
title_sort | addressing current challenges in osl dosimetry using mgb(4)o(7):ce,li: state of the art, limitations and avenues of research |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142933/ https://www.ncbi.nlm.nih.gov/pubmed/37109886 http://dx.doi.org/10.3390/ma16083051 |
work_keys_str_mv | AT bossinlily addressingcurrentchallengesinosldosimetryusingmgb4o7celistateoftheartlimitationsandavenuesofresearch AT plokhikhigor addressingcurrentchallengesinosldosimetryusingmgb4o7celistateoftheartlimitationsandavenuesofresearch AT christensenjeppebrage addressingcurrentchallengesinosldosimetryusingmgb4o7celistateoftheartlimitationsandavenuesofresearch AT gawrylukdariuszjakub addressingcurrentchallengesinosldosimetryusingmgb4o7celistateoftheartlimitationsandavenuesofresearch AT kitagawayuuki addressingcurrentchallengesinosldosimetryusingmgb4o7celistateoftheartlimitationsandavenuesofresearch AT leblanspaul addressingcurrentchallengesinosldosimetryusingmgb4o7celistateoftheartlimitationsandavenuesofresearch AT tanabesetsuhisa addressingcurrentchallengesinosldosimetryusingmgb4o7celistateoftheartlimitationsandavenuesofresearch AT vandenbrouckedirk addressingcurrentchallengesinosldosimetryusingmgb4o7celistateoftheartlimitationsandavenuesofresearch AT yukiharaeduardogardenali addressingcurrentchallengesinosldosimetryusingmgb4o7celistateoftheartlimitationsandavenuesofresearch |